BRPI0818511A2 - Novos compostos de miméticos de giro reverso e uso dos mesmos (1) - Google Patents

Novos compostos de miméticos de giro reverso e uso dos mesmos (1)

Info

Publication number: BRPI0818511A2
Authority: BR; Brazil
Prior art keywords: gyretic; mimetics; reverse; new compounds; compounds
Prior art date: 2007-10-15

Application number

BRPI0818511-5A

Other languages

English (en)

Inventor

Jae Uk Chung

Hee-Kyung Jung

Kyung-Yun Jung

Min-Wook Jeong

Hyun-Ju La

Sang-Hak Lee

Hoe-Moon Kim

Original Assignee

Choongwae Pharma Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-15

Filing date

2008-10-15

Publication date

2015-06-16

2008-10-15 Application filed by Choongwae Pharma Corp filed Critical Choongwae Pharma Corp

2015-06-16 Publication of BRPI0818511A2 publication Critical patent/BRPI0818511A2/pt

2021-09-21 Publication of BRPI0818511B1 publication Critical patent/BRPI0818511B1/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Oncology (AREA)
Immunology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Hematology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

BRPI0818511-5A 2007-10-15 2008-10-15 Compostos de miméticos de giro reverso e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda BRPI0818511B1 (pt)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US11/974.941		2007-10-15
US11/974,941 US7671054B1 (en)	2001-10-12	2007-10-15	Reverse-turn mimetics and method relating thereto
PCT/KR2008/006072 WO2009051399A2 (en)	2007-10-15	2008-10-15	Novel compounds of reverse turn mimetics and the use thereof (1)

Publications (2)

Publication Number	Publication Date
BRPI0818511A2 true BRPI0818511A2 (pt)	2015-06-16
BRPI0818511B1 BRPI0818511B1 (pt)	2021-09-21

Family

ID=40567948

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BRPI0818511-5A BRPI0818511B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de giro reverso e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda
BRPI0818647-2A BRPI0818647B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de volta reversa e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BRPI0818647-2A BRPI0818647B1 (pt)	2007-10-15	2008-10-15	Compostos de miméticos de volta reversa e uso dos mesmos para tratar ou prevenir leucemia mielóide aguda

Country Status (13)

Country	Link
US (4)	US7671054B1 (pt)
EP (3)	EP2212328B1 (pt)
JP (3)	JP5222949B2 (pt)
KR (3)	KR101269420B1 (pt)
CN (4)	CN101827850B (pt)
AU (2)	AU2008312193B2 (pt)
BR (2)	BRPI0818511B1 (pt)
CA (2)	CA2701735C (pt)
ES (3)	ES2541459T3 (pt)
MX (2)	MX2010004046A (pt)
PL (1)	PL2212330T3 (pt)
RU (2)	RU2470024C2 (pt)
WO (3)	WO2009051399A2 (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP3211496B2 (ja)	1993-07-30	2001-09-25	日産自動車株式会社	表面潤滑皮膜処理材およびその製造方法
US7232822B2 (en) *	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en) *	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7566711B2 (en) *	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7671054B1 (en) *	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US8080657B2 (en) *	2001-10-12	2011-12-20	Choongwae Pharma Corporation	Compounds of reverse turn mimetics and the use thereof
CA2629136C (en) *	2005-11-08	2016-03-08	Choongwae Pharma Corporation	.alpha.-helix mimetics and method relating to the treatment of cancer stem cells
AU2009255042B2 (en) *	2008-06-06	2014-05-15	Prism Biolab Corporation	Alpha helix mimetics and methods relating thereto
EP2346871A1 (en)	2008-10-14	2011-07-27	PRISM BioLab Corporation	Alpha helix mimetics in the treatment of cancer
RU2515983C2 (ru) *	2009-04-15	2014-05-20	Джей ДаблЮ ФАРМАСЬЮТИКАЛ КОРПОРЭЙШН	Новые соединения миметиков обратного действия, способ их получения и применения
CN102482258B (zh) *	2009-05-07	2014-06-25	株式会社棱镜制药	α-螺旋模拟物和与其相关的方法
JPWO2011096440A1 (ja)	2010-02-03	2013-06-10	株式会社ＰＲＩＳＭＢｉｏＬａｂ	天然変性タンパク質に結合する化合物およびそのスクリーニング方法
KR102168006B1 (ko)	2010-10-07	2020-10-20	유니버시티 오브 써던 캘리포니아	체세포 줄기 세포의 비대칭 분열을 향상시키기 위한 ｃｂｐ/카테닌 길항제
EP2628741B1 (en) *	2010-10-14	2015-10-07	JW Pharmaceutical Corporation	Novel compound of a reverse-turn mimetic and a production method and use therefor
BR112013012228B1 (pt)	2010-11-16	2023-02-28	University Of Southern California	Método cosmético para tratar uma condição da pele e usos de um composto antagonista de cbp/catenina de molécula pequena
EP2678341A1 (en) *	2011-02-25	2014-01-01	PRISM Pharma Co., Ltd.	Alpha helix mimetics and methods relating thereto
US20140005164A1 (en) *	2011-04-04	2014-01-02	Siena Biotech S.P.A.	Wnt pathway antagonists
KR101441406B1 (ko) *	2011-05-25	2014-11-04	주식회사 바이오이미징코리아	디아릴이오도늄 염 전구체를 이용한 플로오린-18이 표지된 플루마제닐의 제조 방법
US9353119B2 (en) *	2011-08-09	2016-05-31	Jw Pharmaceutical Corporation	Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives
PT2754441E (pt) *	2011-08-09	2016-06-24	Jw Pharmaceutical Corp	Composição para a prevenção e tratamento de cancro do pulmão de não pequenas células, contendo derivados de pirazino-triazina
US20140179633A1 (en) *	2011-08-26	2014-06-26	Jw Pharmaceutical Corporation	Composition comprising pyrazino-triazine derivatives
HK1201061A1 (en)	2011-10-07	2015-08-21	University Of Southern California	Cbp/catenin antagonists for enhancing asymmetric division of somatic stem cells
GB201315335D0 (en)	2013-08-29	2013-10-09	Of Singapore	Amino diacids containing peptide modifiers
WO2015037587A1 (ja) *	2013-09-11	2015-03-19	エーザイ・アール・アンド・ディー・マネジメント株式会社	ピラジノ［２，１－ｃ］［１，２，４］トリアジン化合物の製造方法
US9174998B2 (en)	2013-12-25	2015-11-03	Eisai R&D Management Co., Ltd.	(6S,9aS)-N-benzyl-6-[(4-hydroxyphenyl)methyl]-4,7-dioxo-8-({6-[3-(piperazin-1-yl)azetidin-1-yl]pyridin-2-yl}methyl)-2-(prop-2-en-1-yl)-octahydro-1H-pyrazino[2,1-c][1,2,4]triazine-1-carboxamide compound
MX373231B (es)	2015-06-16	2020-05-08	Eisai R&D Man Co Ltd	Agente anticancerigeno.
KR102559211B1 (ko) *	2015-06-23	2023-07-25	에자이 알앤드디 매니지먼트 가부시키가이샤	(6S,9aS)-N-벤질-8-({6-[3-(4-에틸피페라진-1-일)아제티딘-1-일]피리딘-2-일}메틸)-6-(2-플루오로-4-하이드록시벤질)-4,7-디옥소-2-(프로프-2-엔-1-일)헥사하이드로-2H-피라지노[2,1-c][1,2,4]트리아진-1(6H)-카복사마이드의 결정
GB201511382D0 (en)	2015-06-29	2015-08-12	Imp Innovations Ltd	Novel compounds and their use in therapy
CN108026104B (zh) *	2015-09-18	2021-06-18	国立大学法人鸟取大学	利用低分子化合物的癌及纤维化的抑制和再生促进的效果
WO2017184808A1 (en) *	2016-04-20	2017-10-26	University Of Southern California	Compounds and methods for increasing hematopoiesis
JP6581320B2 (ja)	2017-02-08	2019-09-25	エーザイ・アール・アンド・ディー・マネジメント株式会社	腫瘍治療用医薬組成物
RU2019134940A (ru)	2017-05-16	2021-06-16	Эйсай Ар Энд Ди Менеджмент Ко., Лтд.	Лечение гепатоцеллюлярной карциномы
CN110950873A (zh) *	2019-12-10	2020-04-03	河南大学	坡尔吲哚的合成新方法
WO2021183791A1 (en)	2020-03-12	2021-09-16	City Of Hope	Wnt/cbp/catenin signaling pathway inhibitors and uses thereof
JP7750851B2 (ja)	2020-03-12	2025-10-07	３＋２ファーマリミテッドライアビリティカンパニー	Ｃｂｐ／カテニンシグナル伝達経路阻害薬およびそれらの使用
US20240352020A1 (en) *	2021-08-26	2024-10-24	3+2 Pharma, Llc	Pyrazole-containing cbp/catenin antagonists and uses thereof
GB202209228D0 (en)	2022-06-23	2022-08-10	Univ Strathclyde	Modified amino acids and uses thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3120859A1 (de)	1981-05-26	1982-12-23	Basf Ag, 6700 Ludwigshafen	Dihalogenacetamide, verfahren zu ihrer herstellung und herbizide mittel, die acetanilide als herbizide wirkstoffe und diese dihalogenacetamide als antagonistische mittel enthalten
US5475085A (en)	1991-02-07	1995-12-12	Molecumetics, Ltd.	Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
EP0573608A1 (en)	1991-02-07	1993-12-15	Molecumetics, Ltd.	Conformationally restricted mimetics of beta turns and beta bulges and peptides containing the same
JPH07509723A (ja)	1992-08-06	1995-10-26	モレキュメティクス，リミティド	反転型ターンの立体配座的に拘束されたミメティックスと前者を含有するペプチド
US5446128A (en)	1993-06-18	1995-08-29	The Board Of Trustees Of The University Of Illinois	Alpha-helix mimetics and methods relating thereto
US5693325A (en)	1994-03-15	1997-12-02	Molecumetics, Ltd.	Peptide vaccines and methods relating thereto
US6020331A (en)	1995-03-24	2000-02-01	Molecumetics, Ltd.	β-sheet mimetics and use thereof as protease inhibitors
US6245764B1 (en)	1995-03-24	2001-06-12	Molecumetics Ltd.	β-sheet mimetics and use thereof as inhibitors of biologically active peptides or proteins
US5929237A (en)	1995-10-27	1999-07-27	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
US5840833A (en)	1995-10-27	1998-11-24	Molecumetics, Ltd	Alpha-helix mimetics and methods relating thereto
US6184223B1 (en)	1995-10-27	2001-02-06	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
US6013458A (en)	1995-10-27	2000-01-11	Molecumetics, Ltd.	Reverse-turn mimetics and methods relating thereto
ATE320811T1 (de)	1996-08-05	2006-04-15	Myriad Genetics Inc	Verwendung von beta-blatt mimetika als protease und kinase hemmer und alshemmer eines transkriptionsfaktors
US6117896A (en)	1997-02-10	2000-09-12	Molecumetics Ltd.	Methods for regulating transcription factors
US6451972B1 (en)	1998-11-16	2002-09-17	Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.	Peptido-mimetic compounds containing RGD sequence useful as integrin inhibitors
US6294525B1 (en)	1999-09-01	2001-09-25	Molecumetics Ltd.	Reverse-turn mimetics and methods relating thereto
CA2284459C (en)	1999-10-04	2012-12-11	Neokimia Inc.	Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery
US6872825B2 (en)	1999-12-21	2005-03-29	The Procter & Gamble Company	Peptide β-turn mimetic compounds and processes for making them
DE10005631A1 (de)	2000-02-09	2001-08-23	Max Planck Gesellschaft	Arginin-Mimetika als Faktor X¶a¶-Inhibitoren
US7662960B2 (en)	2001-04-26	2010-02-16	Choongwae Pharma Corporation	Beta-strand mimetics and method relating thereto
US20040204477A1 (en)	2001-07-09	2004-10-14	Juergen Moll	Interaction inhibitors of tcf-4 with beta-catenin
WO2003030907A1 (en) *	2001-10-09	2003-04-17	Myriad Genetics, Inc.	Reverse-turn mimetics and composition and methods relating thereto
US7232822B2 (en) *	2001-10-12	2007-06-19	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US20040072831A1 (en) *	2001-10-12	2004-04-15	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7576084B2 (en)	2001-10-12	2009-08-18	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
JP4387793B2 (ja) *	2001-10-12	2009-12-24	チョンウェファーマコーポレーション	逆向ターンミメティックおよびそれに関連した方法
US7566711B2 (en) *	2001-10-12	2009-07-28	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US7671054B1 (en) *	2001-10-12	2010-03-02	Choongwae Pharma Corporation	Reverse-turn mimetics and method relating thereto
US6762185B1 (en)	2002-03-01	2004-07-13	Choongwae Pharma Corporation	Compounds useful for treatment of cancer, compositions containing the same, and methods of their use
JP2006517550A (ja)	2003-02-13	2006-07-27	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	置換ヘキサヒドロピラジノ［１，２−ａ］ピリミジン−４，７−ジオン誘導体、その製造方法および医薬としてのその使用
RS20050572A (sr)	2003-02-13	2007-09-21	Sanofi-Aventis Deutschland Gmbh.,	AZOTOM SUPSTITUISANI HEKSAHIDRO- PIRAZINO(1,2-A)PIRIMIDIN -4,7-DION DERIVATI, POSTUPAK ZA NjIHOVU PROIZVODNjU I NjIHOVA PRIMENA KAO LEKA
KR20060121842A (ko) *	2003-08-28	2006-11-29	주식회사 중외제약	β-카테닌/ＴＣＦ에 의해 활성화되는 전사의 조절
CA2629136C (en)	2005-11-08	2016-03-08	Choongwae Pharma Corporation	.alpha.-helix mimetics and method relating to the treatment of cancer stem cells
JP2009517085A (ja)	2005-11-28	2009-04-30	チョンウェファーマコーポレイション	培養における細胞の無血清増殖
AU2009255042B2 (en)	2008-06-06	2014-05-15	Prism Biolab Corporation	Alpha helix mimetics and methods relating thereto

2007
- 2007-10-15 US US11/974,941 patent/US7671054B1/en not_active Expired - Fee Related
2008
- 2008-10-15 BR BRPI0818511-5A patent/BRPI0818511B1/pt not_active IP Right Cessation
- 2008-10-15 EP EP08839260.0A patent/EP2212328B1/en not_active Not-in-force
- 2008-10-15 CN CN200880111810.7A patent/CN101827850B/zh not_active Expired - Fee Related
- 2008-10-15 BR BRPI0818647-2A patent/BRPI0818647B1/pt active IP Right Grant
- 2008-10-15 ES ES08840475.1T patent/ES2541459T3/es active Active
- 2008-10-15 MX MX2010004046A patent/MX2010004046A/es active IP Right Grant
- 2008-10-15 ES ES08839568.6T patent/ES2509042T3/es active Active
- 2008-10-15 CN CN201310424477.8A patent/CN103539797B/zh active Active
- 2008-10-15 EP EP08840475.1A patent/EP2212330B1/en active Active
- 2008-10-15 PL PL08840475T patent/PL2212330T3/pl unknown
- 2008-10-15 WO PCT/KR2008/006072 patent/WO2009051399A2/en not_active Ceased
- 2008-10-15 AU AU2008312193A patent/AU2008312193B2/en not_active Ceased
- 2008-10-15 JP JP2010529858A patent/JP5222949B2/ja not_active Expired - Fee Related
- 2008-10-15 KR KR1020107010682A patent/KR101269420B1/ko active Active
- 2008-10-15 CA CA2701735A patent/CA2701735C/en active Active
- 2008-10-15 CA CA2702461A patent/CA2702461C/en not_active Expired - Fee Related
- 2008-10-15 US US12/682,881 patent/US8071764B2/en not_active Expired - Fee Related
- 2008-10-15 KR KR1020107010576A patent/KR101542921B1/ko not_active Expired - Fee Related
- 2008-10-15 ES ES08839260.0T patent/ES2622703T3/es active Active
- 2008-10-15 JP JP2010529859A patent/JP5400785B2/ja not_active Expired - Fee Related
- 2008-10-15 RU RU2010119468/04A patent/RU2470024C2/ru active
- 2008-10-15 AU AU2008312191A patent/AU2008312191B2/en active Active
- 2008-10-15 KR KR1020107010575A patent/KR101229504B1/ko not_active Expired - Fee Related
- 2008-10-15 CN CN2008801116629A patent/CN101827849B/zh not_active Expired - Fee Related
- 2008-10-15 RU RU2010119447/04A patent/RU2457210C2/ru active
- 2008-10-15 WO PCT/KR2008/006071 patent/WO2009051398A2/en not_active Ceased
- 2008-10-15 MX MX2010004045A patent/MX2010004045A/es active IP Right Grant
- 2008-10-15 WO PCT/KR2008/006070 patent/WO2009051397A2/en not_active Ceased
- 2008-10-15 JP JP2010529857A patent/JP5222948B2/ja active Active
- 2008-10-15 CN CN2008801207859A patent/CN101896485A/zh active Pending
- 2008-10-15 EP EP08839568.6A patent/EP2212329B1/en not_active Not-in-force
2009
- 2009-12-29 US US12/649,161 patent/US8138337B2/en not_active Expired - Fee Related
2010
- 2010-04-07 US US12/756,095 patent/US8049008B2/en active Active

Also Published As

Publication number	Publication date
US20100240662A1 (en)	2010-09-23
WO2009051399A3 (en)	2009-06-04
ES2509042T3 (es)	2014-10-16
JP5222948B2 (ja)	2013-06-26
CA2702461A1 (en)	2009-04-23
CN103539797B (zh)	2016-05-18
RU2010119447A (ru)	2011-11-27
AU2008312193B2 (en)	2012-10-18
JP2011500668A (ja)	2011-01-06
WO2009051397A2 (en)	2009-04-23
BRPI0818511B1 (pt)	2021-09-21
RU2010119468A (ru)	2011-11-27
CA2701735A1 (en)	2009-04-23
EP2212329A4 (en)	2011-11-30
EP2212330A2 (en)	2010-08-04
US8049008B2 (en)	2011-11-01
WO2009051397A3 (en)	2009-06-04
EP2212330B1 (en)	2015-04-08
EP2212328A2 (en)	2010-08-04
EP2212330A4 (en)	2011-11-30
ES2541459T3 (es)	2015-07-20
CN101827850B (zh)	2014-03-12
US8138337B2 (en)	2012-03-20
WO2009051397A9 (en)	2010-05-27
WO2009051398A2 (en)	2009-04-23
AU2008312193A1 (en)	2009-04-23
BRPI0818647B1 (pt)	2021-10-26
MX2010004046A (es)	2010-06-25
CN101896485A (zh)	2010-11-24
JP5222949B2 (ja)	2013-06-26
US7671054B1 (en)	2010-03-02
WO2009051398A3 (en)	2009-06-04
AU2008312191B2 (en)	2012-07-05
JP2011500666A (ja)	2011-01-06
KR20100099116A (ko)	2010-09-10
CA2701735C (en)	2012-12-11
ES2622703T3 (es)	2017-07-07
CA2702461C (en)	2012-12-11
EP2212328A4 (en)	2011-11-30
CN101827849B (zh)	2013-07-24
RU2457210C2 (ru)	2012-07-27
CN103539797A (zh)	2014-01-29
PL2212330T3 (pl)	2015-09-30
CN101827850A (zh)	2010-09-08
US20100222303A1 (en)	2010-09-02
CN101827849A (zh)	2010-09-08
JP5400785B2 (ja)	2014-01-29
MX2010004045A (es)	2010-07-06
EP2212329A2 (en)	2010-08-04
EP2212329B1 (en)	2014-07-30
AU2008312191A1 (en)	2009-04-23
RU2470024C2 (ru)	2012-12-20
KR101229504B1 (ko)	2013-02-04
KR20100085107A (ko)	2010-07-28
US20100228027A1 (en)	2010-09-09
US8071764B2 (en)	2011-12-06
KR101542921B1 (ko)	2015-08-11
KR20100085102A (ko)	2010-07-28
WO2009051399A2 (en)	2009-04-23
EP2212328B1 (en)	2017-01-25
BRPI0818647A2 (pt)	2015-04-07
KR101269420B1 (ko)	2013-05-30
JP2011500667A (ja)	2011-01-06

Publication	Publication Date	Title
BRPI0818511A2 (pt)	2015-06-16	Novos compostos de miméticos de giro reverso e uso dos mesmos (1)
BRPI0808013A2 (pt)	2014-06-17	Compostos de quinoxalina e uso dos mesmos
PT2124638T (pt)	2017-03-13	Composição de aperfeiçoamento de desempenho e utilização da mesma
BRPI0716327A2 (pt)	2014-03-04	Composto de fenilpropionamida e uso
BRPI0813355A2 (pt)	2014-12-30	Compostos de quinazolinona e métodos de uso dos mesmos
BRPI0815811A2 (pt)	2015-02-18	Derivados de indol substituído e métodos de uso dos mesmos
CR10743A (es)	2009-06-05	Derivados de azaadamantano y metodos de uso de los mismos
BRPI0820457A2 (pt)	2015-06-16	Fluidos de ruptura e métodos de uso dos mesmos
BRPI0720625A2 (pt)	2014-03-25	Derivados de indol de 4,5-anel anulados e métodos de uso dos mesmos
BRPI0909954A2 (pt)	2015-11-03	"diazacarbazóis e métodos de uso"
BRPI0923725A2 (pt)	2015-08-04	"compostos absorventes de uv trifuncionais e uso dos mesmos".
CR10725A (es)	2009-05-12	Compuestos de pirazolina y su uso y composiones farmaceuticas
FI20075532A0 (fi)	2007-07-10	Uusia esteraaseja ja niiden käyttö
BRPI0807495A2 (pt)	2014-05-20	Adjuvantes e métodos de emrpego dos mesmos
BRPI0813770A2 (pt)	2014-12-30	Composição, e, uso de uma composição
BRPI0813457A2 (pt)	2014-12-23	Composto de organoenxofre contendo halogênio e uso do mesmo
DK1954953T3 (da)	2011-09-12	Gevindforbindelser med coatinger med høj og lav friktion
BRPI0813627A2 (pt)	2014-12-23	Peptídio antimicrobiano, composições e métodos de uso
BRPI0614205A2 (pt)	2016-11-22	composto, composição farmacêutica, e, uso de composto
BR112012003661A2 (pt)	2017-04-25	"compostos de biarila e métodos de uso dos mesmos."
BRPI0907365A2 (pt)	2015-07-14	Composição antimicrobiana e uso
BRPI0821668A2 (pt)	2015-06-16	Uso
SMT201500218B (it)	2015-10-30	Composti aril-fenil-solfonammido-cicloalchile e loro uso
DK2001556T3 (da)	2014-11-10	Thioninium-forbindelser og anvendelse deraf
BRPI0812909A2 (pt)	2014-12-09	Derivados de guanina policíclica e métodos de uso dos mesmos.

Legal Events

Date	Code	Title	Description
2018-04-17	B06F	Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
2020-06-23	B07D	Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]	Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.
2020-11-17	B07E	Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
2020-12-01	B06U	Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
2021-03-30	B06A	Patent application procedure suspended [chapter 6.1 patent gazette]
2021-07-06	B09A	Decision: intention to grant [chapter 9.1 patent gazette]
2021-09-21	B16A	Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]	Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 15/10/2008, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.
2022-08-09	B21F	Lapse acc. art. 78, item iv - on non-payment of the annual fees in time	Free format text: REFERENTE A 14A ANUIDADE.
2022-11-29	B24J	Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)	Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2692 DE 09-08-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.